Cytosorbents: Boral Capital Maintains Buy Rating, Raises PT to $10

Monday, Jan 12, 2026 8:49 am ET1min read
CTSO--

Cytosorbents: Boral Capital Maintains Buy Rating, Raises PT to $10

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet